Sven Wehrwein, Director at AtriCure, Inc. (ATRC), sold 10,000 shares at $77.75 ($780K) on 2021-05-03, disclosed to the SEC on 2021-05-05.
Seasonal sale ($780k) by Director — this insider has traded ATRC in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.75 | 5,000 | $389K | 49.9% |
| 2 | $78.19 | 5,000 | $391K | 50.1% |
| Total | $77.97 avg | 10,000 | $780K | 100% |
| Filing → |
| ATRC | SELL | 2025-11-26 | $564K | — | Filing → |
| ATRC | SELL | 2025-08-26 | $185K | — | Filing → |
| ATRC | SELL | 2025-08-21 | $180K | — | Filing → |